RxDoctor Payments Data

Michael Kelley

Hematology & Oncology · Durham, NCNPI 1316048408

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Novartis. That places this record below the midpoint for hematology & oncology clinicians in NC, where the typical reported total is $1,703.

$73in general payments, 2019–2025

Across 1 payment — averaging $73.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$73
$672,293in research payments, 2019–2025

Across 80 payments — averaging $8403.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$250K
  • Regeneron$243K
  • Merck$70K
  • E.r. Squibb & Sons, L.L.C.$52K
  • Genentech, Inc.$24K
  • Novartis$20K
  • plus $12K from 2 others

What the payments were for

  • Food & beverage$73100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis1$73

How this compares

$73 in reported general payments places this provider in the 10th percentile of 358 hematology & oncology providers in North Carolina.

See all hematology & oncology providers in North Carolina

Other hematology & oncology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →